首页 | 本学科首页   官方微博 | 高级检索  
     


The therapeutic potential of chemical chaperones in protein folding diseases
Authors:Leonardo Cortez  Valerie Sim
Affiliation:Department of Medicine - Division of Neurology; Centre for Prions and Protein Folding Diseases; University of Alberta; Edmonton, AB Canada
Abstract:Several neurodegenerative diseases are caused by defects in protein folding, including Alzheimer, Parkinson, Huntington, and prion diseases. Once a disease-specific protein misfolds, it can then form toxic aggregates which accumulate in the brain, leading to neuronal dysfunction, cell death, and clinical symptoms. Although significant advances have been made toward understanding the mechanisms of protein aggregation, there are no curative treatments for any of these diseases. Since protein misfolding and the accumulation of aggregates are the most upstream events in the pathological cascade, rescuing or stabilizing the native conformations of proteins is an obvious therapeutic strategy. In recent years, small molecules known as chaperones have been shown to be effective in reducing levels of misfolded proteins, thus minimizing the accumulation of aggregates and their downstream pathological consequences. Chaperones are classified as molecular, pharmacological, or chemical. In this mini-review we summarize the modes of action of different chemical chaperones and discuss evidence for their efficacy in the treatment of protein folding diseases in vitro and in vivo.
Keywords:TUDCA   DCA   UDCA   PBA   osmolytes   protein folding diseases   chemical chaperones   protein misfolding
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号